表紙
市場調查報告書

印度的線上藥局市場

Online Pharmacy Market in India 2023

出版商 NAVADHI Market Research Pvt Ltd 商品編碼 871606
出版日期 內容資訊 英文 68 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的線上藥局市場 Online Pharmacy Market in India 2023
出版日期: 2019年06月21日內容資訊: 英文 68 Pages
簡介

本報告提供印度國內的線上藥局的市場相關分析,市場整體結構最新形勢,主要的推動及阻礙市場要素,市場規模趨勢預測 (今後6年份),市場整體向心力 、相關政府機關、產業團體的資訊,相關市場 (製藥企業整體)的趨勢、動靜,主要企業的簡介等資訊彙整,為您概述為以下內容。

第1章 摘要整理

第2章 印度的藥局市場:概要

  • 製藥產業的相關用語:概要
  • 製藥產業上研究開發 (R&D)的各階段
  • 產業整體研究開發 (R&D) 投資額
  • 研究開發 (R&D) 投資額:各階段
  • 印度的製藥產業:價值鏈分析

第3章 印度國內的藥局市場需求

  • 人口增加和高齡化
  • 下、中級階層的所得水準的上升
  • 醫藥品的安全性

第4章 印度的線上藥局市場未來預測

  • 線上藥局市場未來預測 (今後6年份)

第5章 印度的線上藥局市場成長促進、阻礙因素

第6章 印度國內的製藥產業相關的製作

  • 中央政府的各種政策
  • 製藥產業銷售活動相關指南
  • 印度國內的線上藥局法規方案:概要

第7章 印度的醫藥品相關的產業團體

  • IDMA (印度醫藥品廠商協會)
  • IPMMA (印度製藥機器廠商協會)
  • IPA (印度製藥產業協會)
  • OPPI (印度製藥企業機構)
  • AIMED (印度醫療設備產業協會)

第8章 印度的醫藥品市場相關的政府機關

  • 醫藥品局 (Department of Pharmaceuticals)
  • 化學、肥料省 (Ministry of Chemicals & Fertilizers)
  • 國家醫藥品價格局 (National Pharmaceutical Pricing Authority: NPPA)

第9章 印度的線上藥局市場:主要企業的簡介

  • PharmEasy
    • 企業簡介
    • 醫藥品零售業的價值鏈的地位
    • 事業策略
    • SWOT分析
  • Myra
  • NetMeds Marketplace Limited

第10章 印度醫院藥局產業的相關風險

  • 信用風險
  • 政策風險
  • 技術風險

第11章 印度醫院藥局市場分析

  • 大環境分析:印度醫院藥局市場
  • 波特的五力分析
    • 新加入企業的威脅
    • 替代產品的威脅
    • 供應商談判力
    • 買主談判力
    • 企業間競爭
  • SWOT分析
    • 強度、弱、機會、威脅

第12章 未來趨勢:印度醫院藥局市場

目錄
Product Code: NAV0619021

Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions and emergence of new diseases help increase the demand for various medicines. Online pharmacy market in India is expected to see a steady growth with the rising high-speed internet penetration, rising smartphone and e-commerce usage.

"Indian online pharmacy market is expected to be worth USD 2.35 billion by 2023."

As per NAVADHI Market Research, the Indian online pharmacy industry will we worth USD 2.35 billion and will have a market share of 7.08% in India's pharmaceuticals market by 2023. The growth in this market is predicted on the basis of various factors like market drivers, current and upcoming trends, current growth pattern, and market challenges.

This growth is fueled by the growing and ageing population in India. More than 6% of Indian population is above 65 years of age and this number is expected to rise by 2023. Apart from ageing and rising population the improvements in purchasing power and access to quality healthcare and pharmaceuticals to poor and middle-class families is also driving the growth of Indian pharma industry. Indian people spend 64.21% of their health expenditure from out-of-pocket of which pharmaceuticals spend accounts for 51.67%. Increased access to high speed internet and rising smartphone usage had made it possible to access e-commerce websites even in rural and remote areas of India. This along with ease of use, home-delivery of medicines, no fear of counterfeit medicines and around 15-20% discount on MRP of medicines offered by online pharmacies are bigger draw for consumers.

On the other hand, lack of any regulatory framework for the e-pharmacy market is the major growth inhibitor for online pharmacy market in India. In August 2018, the Union Health Ministry come out with draft rules amendments to the Drugs and Cosmetics Act on sale of drugs by e-pharmacies in India with an aim to regulate online sale of medicines and provide patients accessibility to genuine drugs from authentic online portals. The newly re-elected Mr. Narendra Modi government has planned to finalize online pharmacy rules it it's 100-day agenda.

In December 2018, the Delhi high court ordered all e-pharmacies in the country to close their operations by 20th December 2018. In the same month, the Madras high court acting on an appeal filed by a group of online pharmacy companies suspended the ban.

As India's online phamacy it is expected to eat into the market share of traditional brick-and-mortar pharma retail market. Brick-and-mortar pharma retailers who make up over eight lakh of the country's voter base have opposed the move to allow e-pharmacies to sell medicines, arguing easy availability of drugs can lead to misuse.

Aggressive drug price control mechanism like Government mandated drug price controls using drug price control order (DPCO) which is an order issued by the Government of India under Section 3 of the Essential Commodities Act, 1955 empowering it to fix and regulate the prices of essential bulk drugs and their formulations have increased the margin pressure for pharma retail companies in India. This can have adverse impact on online pharmacies as they need to heavily invest in technology, operations and logistics. They also rely on offering heavy discounts to customers to gain market share which may not be possible under eroding margins. This can lead to same situation as faced by major consumer e-commerce players in India like Amazon, Flipkart etc.

Also government operated Jan Aushadhi Kendra (pharmacy stores) which offer medicines at discounted rates are expected to give tough competition to online pharma stores which can affect their profit margins. Timely availability of critical care medicines especially in Tier-II, III and IV markets are a major challenge for online pharmacies in India. To tackle this challenge players like NetMeds are planning to setup brick-and-mortar pharmacies themselves.

Spanning over 68 pages and 37 exhibits, “Online Pharmacy Market in India 2023” report provides in-depth analysis for the Indian online pharmacy market for the year FY2018 to FY2023, including market structure, market trends, market constraints and industry drivers.

Scope of the Online Pharmacy Market in India 2023 Report:

  • This report provides detailed information about Indian online pharmacy market including future market forecasts up to 2023.
  • This report identifies the need for focusing on Indian pharmaceuticals market
  • The report identifies the growth drivers and inhibitors for Indian online pharmacy market.
  • This report provides information about policies related to online pharmacy industry in India.
  • This report provides information about industry associations and government bodies related to Indian pharmaceuticals industry.
  • The report identifies various risks associated with Indian online pharmacy market.
  • This report has detailed profiles 3 key players in Indian pharma retail market covering their position in pharma retail value chain, business strategy and SWOT analysis.
  • This report provides PESTEL (political, economic, social, technological, environmental and legal) analysis for Indian pharmaceuticals market.
  • This report provides Porter's Five Forces analysis for Indian pharmacy retail market.
  • This report provides SWOT (strengths, weakness, opportunities and threats) analysis for Indian online pharmacy market.
  • This report provides information about future trends in Indian online pharmacy market.

Countries Covered:

India.

Table of Contents

1. Executive Summary

  • Scope of the Online Pharmacy Market in India 2023 Report
  • Research Methodology

2. Introduction of Indian Pharmaceuticals Market

  • Key Product Terms Used in Pharmaceuticals Industry
    • Pharmaceuticals
    • Innovative Drugs
    • Orphan Drugs
    • Generic Drugs
    • Commodity Generic Drugs
    • Branded Generic Drugs
    • Biologics
    • Biosimilars
    • Over-the-counter (OTC) Drugs
    • Active Pharmaceutical Ingredients (APIs)
    • Excipients
  • Research and Development (R&D) Phases of Pharmaceuticals Industry
  • Industry-Wise Research and Development (R&D) Investment
  • Phase Wise Research and Development (R&D) Investment in Pharmaceuticals Industry
  • Indian Pharmaceuticals Industry Value Chain Analysis

3. Need for Indian Pharmaceuticals Market

  • 3.1. Rising & Ageing Population
  • 3.2. Increasing Income Levels of Poor & Middle-Class Families
  • 3.3. Drug Security

4. Forecast for Online Pharmacy Market in India 2023

  • 4.1. Forecast for Online Pharmacy Market in India 2018-2023
    • 4.1.1. Forecast for India Online Pharmacy Market 2018-2023

5. Growth Drivers and Inhibitors for Online Pharmacy Market in India

6. Policies Related to Online Pharmacy Industry in India

  • 6.1. Central Government Policies
    • 6.1.1. Essential Commodities Act 1955
    • 6.1.2. Drugs and Cosmetics Act 1940(As amended in June 2005)
    • 6.1.3. National Pharmaceutical Pricing Policy 2012
    • 6.1.4. Drug Price Control Orders (DPCO)
    • 6.1.5. Drug Policy 1986
    • 6.1.6. Pharmaceutical Policy - 2002
  • 6.2. Guidelines related to Marketing in Indian Pharmaceuticals Industry
  • 6.3. Highlights of Draft Regulation for e-Pharmacy Market in India

7. Industry Associations Related to Indian Pharmaceuticals Market

  • 7.1. Indian Drug Manufacturers' Association (IDMA)
  • 7.2. Indian Pharma Machinery Manufacturers Association (IPMMA)
  • 7.3. Indian Pharmaceutical Association (IPA)
  • 7.4. Organisation of Pharmaceutical Producers of India (OPPI)
  • 7.5. Association of Indian Medical Device Industry (AIMED)

8. Government Bodies Related to Indian Pharmaceuticals Market

  • 8.1. Department of Pharmaceuticals
  • 8.2. Ministry of Chemicals & Fertilizers
  • 8.3. National Pharmaceutical Pricing Authority (NPPA)

9. Profile of Key Players in Indian Online Pharmacy Market

  • 9.1. PharmEasy
    • 9.1.1. Company Profile
    • 9.1.2. PharmEasy in Pharma Retail Value Chain
    • 9.1.3. PharmEasy Business Strategy
    • 9.1.4. SWOT Analysis of PharmEasy
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 9.2. Myra
    • 9.2.1. Company Profile
    • 9.2.2. Myra in Pharma Retail Value chain
    • 9.2.3. Myra Business Strategy
    • 9.2.4. SWOT Analysis of Myra
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats
  • 9.3. NetMeds Marketplace Limited
    • 9.3.1. Company Profile
    • 9.3.2. NetMeds Marketplace Limited in Pharma Retail Value chain
    • 9.3.3. SWOT Analysis of NetMeds Marketplace Limited
      • Strengths
      • Weaknesses
      • Opportunities
      • Threats

10. Risks Associated with Indian Online Pharmacy Industry

  • 10.1. Credit Risks
  • 10.2. Policy Risk
  • 10.3. Technical Risk

11. Analysis of Online Pharmacy Market in India

  • 11.1. PESTLE Analysis of India Pharmaceuticals Market
  • 11.2. Porter's Five Forces Analysis of Indian Online Pharmacy Market
    • Threat of New Entrants
    • Threat of Substitutes
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Competitive Rivalry
  • 11.3. SWOT Analysis of Indian Online Pharmacy Industry
    • Strengths
    • Weaknesses
    • Opportunities
    • Threats

12. Future Trends in Indian Online Pharmacy Market

  • List of Exhibits
  • Notes
  • Company Information

List of Exhibits

  • Exhibit 2.1: Research and Development Phases of Pharmaceuticals Industry
  • Exhibit 2.2: Industry-Wise Research and Development Investment in Comparison to Net Sales (in %)
  • Exhibit 2.3: Phase-Wise Research and Development Investment in Pharmaceuticals Industry
  • Exhibit 2.4: Indian Pharmaceuticals Industry Value Chain Analysis
  • Exhibit 3.1: India Population Forecast 2016-2023 (in millions)
  • Exhibit 3.2: Purchasing Power Parity Based Per Capita GDP Forecast for India 2016-2023 (in USD)
  • Exhibit 4.1: Segment-wise Market Share of Indian Pharma Retail (Pharmacy) Market in 2017 (in %)
  • Exhibit 4.2: Population Forecast for India 2016-2023 (in millions)
  • Exhibit 4.3: Forecast for India Online Pharmacy Market 2018-2023 (in USD billion)
  • Exhibit 4.4: Growth Forecast for Online Pharmacy Market in India 2018-2023 (in %)
  • Exhibit 5.1: Growth Drivers and Inhibitors for Online Pharmacy Market in India
  • Exhibit 6.1: Code for Marketing practices in Indian Pharmaceuticals Industry
  • Exhibit 6.2: Highlights of Draft Regulation for e-Pharmacy Market in India
  • Exhibit 7.1: Key information of IDMA
  • Exhibit 7.2: Contact details of IDMA
  • Exhibit 7.3: Key information of IPMMA
  • Exhibit 7.4: Contact details of IPMMA
  • Exhibit 7.5: Key Information of IPA
  • Exhibit 7.6: Contact details of IPA
  • Exhibit 7.7: Key information of OPPI
  • Exhibit 7.8: Contact details of OPPI
  • Exhibit 7.9: Contact information for AIMED
  • Exhibit 9.1: Key Information of PharmEasy
  • Exhibit 9.2: Contact information of PharmEasy
  • Exhibit 9.3: PharmEasy in Pharma Retail Industry Value Chain
  • Exhibit 9.4: SWOT Analysis of PharmEasy
  • Exhibit 9.5: Key information of Myra
  • Exhibit 9.6: Contact Information of Myra
  • Exhibit 9.7: Myra in Pharma Retail Industry Value Chain
  • Exhibit 9.8: SWOT Analysis of Myra
  • Exhibit 9.10: Key information of NetMeds
  • Exhibit 9.11: Contact Information of NetMeds
  • Exhibit 9.12: NetMeds in Pharma Retail Industry Value Chain
  • Exhibit 9.13: SWOT Analysis of NetMeds Marketplace Limited
  • Exhibit 11.1: PESTEL Analysis of the Indian Pharmaceuticals Industry
  • Exhibit 11.2: Porter's Five Forces Analysis for Indian Online Pharmacy Market
  • Exhibit 11.3: SWOT Analysis of Indian Online Pharmacy Industry
Back to Top